Pulse Biosciences Inc año OPV
¿Qué es el año OPV de Pulse Biosciences Inc?
El año OPV de Pulse Biosciences Inc es 2016
¿Cuál es la definición de año OPV?
La oferta pública inicial es un tipo de oferta pública en la cual las acciones de una compañía generalmente se venden a inversionistas institucionales que, a su vez, venden al público en general, en una bolsa de valores, por primera vez.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
año OPV de compañías en Sector Health Care en NASDAQ en comparadas con Pulse Biosciences Inc
¿Qué hace Pulse Biosciences Inc?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Empresas con año opv similar a Pulse Biosciences Inc
- The Toronto-Dominion Bank PFD SER 9 3.7% tiene año OPV de 2015
- Fura Gems tiene año OPV de 2015
- Hostess Brands tiene año OPV de 2015
- Nabriva Therapeutics Plc tiene año OPV de 2015
- REF tiene año OPV de 2015
- H-Source tiene año OPV de 2015
- Pulse Biosciences Inc tiene año OPV de 2016
- American Pacific Borates tiene año OPV de 2017
- Razer tiene año OPV de 2017
- DEAG Deutsche Entertainment Aktiengesellschaft tiene año OPV de 2017
- Hamilton Beach Brands Co tiene año OPV de 2017
- Artelo Biosciences tiene año OPV de 2017
- VARTA AG tiene año OPV de 2017